Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second malignancies following pure seminoma.

U Rüther1, K P Dieckmann, R Bussar-Maatz

  • 1Zentrum für Innere Medizin, Klinik für Allgemeine Innere Medizin, Katharinenhospital, Stuttgart, Deutschland.

Oncology
|January 25, 2000
PubMed
Summary

Patients with pure testicular seminoma face an increased risk of developing second cancers, particularly other testicular tumors and renal cell cancer. This highlights the need for vigilant follow-up after initial treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of the novel serum biomarker of testicular germ cell tumours miR-371a-3p in serum of pregnant women: a case-control study.

European journal of medical research·2025
Same author

Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer.

World journal of urology·2021
Same author

The association of Greig syndrome and mastocytosis reveals the involvement of the hedgehog pathway in advanced mastocytosis.

Blood·2021
Same author

[Knowledge and early detection of testicular germ cell cancer among adolescents and young adults].

Der Urologe. Ausg. A·2019
Same author

Testicular epidermoid cysts: a reevaluation.

BMC urology·2019
Same author

[Assessment of physicians? : Results of a sample analysis for the selection of physicians for staff positions].

Der Urologe. Ausg. A·2017

Area of Science:

  • Oncology
  • Cancer Epidemiology
  • Medical Treatment Outcomes

Background:

  • Testicular seminoma is a significant cancer diagnosis.
  • Understanding long-term risks after treatment is crucial for patient management.
  • Previous studies suggest potential links between testicular cancer treatment and secondary malignancies.

Purpose of the Study:

  • To investigate the incidence and risk of second malignancies in patients treated for pure testicular seminoma.
  • To identify potential adverse late effects of treatment for testicular cancer.
  • To assess the significance of second cancers during patient follow-up.

Main Methods:

  • A multicentric study observed 839 consecutive patients with pure testicular seminoma.
  • Median follow-up was 3.9 years; patients with prior malignancies were excluded.

Related Experiment Videos

  • Treatment modalities included radiotherapy (758 patients), chemotherapy (76 patients), and surveillance (5 patients).

    • Main Results:

    • Twenty-two second cancers were recorded, including 13 contralateral testicular tumors and 9 extratesticular malignancies.
    • The overall risk of a second cancer was significantly increased (RR = 4.8).
    • A markedly higher risk was observed for subsequent testicular tumors (RR = 44.8) and renal cell cancer (RR = 12.5).

    Conclusions:

    • The study confirms an elevated risk of second testicular germ cell cancers post-treatment.
    • A small but significant increase in non-testicular second cancers, including renal cell cancer, was noted.
    • Non-treatment-related factors, such as genetic predisposition, may contribute to second tumor development, necessitating ongoing surveillance.